Alfonso Masucci is a seasoned pharmaceutical executive with extensive experience in marketing and sales leadership, particularly in the respiratory and orphan disease sectors. Currently serving as Senior Vice President at Boehringer Ingelheim since July 2013, Masucci oversees strategy development and execution for interstitial lung disease products and COPD, while also engaging in annual budget planning and cross-functional collaboration. Prior roles include Vice President of Orphan Pulmonary and Liver Disease at Boehringer Ingelheim, where strategic marketing initiatives were implemented for specialty franchises. Earlier in the career, Masucci led global marketing for Hepatitis products at Merck Sharp & Dohme, generating significant revenue and managing diverse promotional campaigns. Masucci's robust background also includes pivotal roles at Roche Pharmaceuticals, where responsibilities ranged from market development to business unit leadership. Masucci holds an MBA in Marketing and Finance from Fairleigh Dickinson University and a degree from Upsala College.